capecitabine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aapro, M; Bondarenko, I; Campone, M; Krishnamurthy, S; Lebedeva, L; Martin, M; Roman, L; Sakaeva, D; Vedovato, JC | 1 |
| Chen, Y; Dai, G; Gu, X; Shi, Y; Wang, Y; Yin, H | 1 |
| Aisu, N; Hirata, K; Hoshino, S; Kojima, D; Mogi, A; Tanimura, S; Yamada, T; Yamashita, Y; Yoshida, Y | 1 |
| Alip, A; Bustam, AZ; Phua, VC; Saad, M; Tan, PL; Wan Ishak, WZ; Wong, WQ | 1 |
1 trial(s) available for capecitabine and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Chemotherapy-Induced Febrile Neutropenia; Drug Resistance, Neoplasm; Female; Hand-Foot Syndrome; Humans; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Progression-Free Survival; Quality of Life; Survival Analysis; Taxoids; Vinblastine | 2018 |
3 other study(ies) available for capecitabine and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with advanced gastric cancer undergoing first-line chemotherapy with oxaliplatin and capecitabine: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxaliplatin; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Treatment Outcome | 2018 |
Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy-Induced Febrile Neutropenia; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neutrophils; Oxaloacetates; Predictive Value of Tests; Risk Factors | 2015 |
Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in asian cancer patients in clinical practice.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy-Induced Febrile Neutropenia; Drug Utilization; Female; Follow-Up Studies; Humans; Malaysia; Male; Middle Aged; Practice Patterns, Physicians'; Prognosis; Survival Rate; Young Adult | 2015 |